CLINICAL_TRIALS
trial_result
· 2017-07-25
Clinical Trial Update: Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) [Phase 3]
Summary
Phase 3 trial update on the efficacy and safety of sarilumab and adalimumab monotherapy in rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-07-25